Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,450 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $555.99 | 5 | $0 (2024) |
| ITI, Inc. | $497.23 | 4 | $0 (2023) |
| ABBVIE INC. | $123.77 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $78.32 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $58.83 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $37.53 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $28.95 | 1 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $22.85 | 1 | $0 (2024) |
| Biogen, Inc. | $17.37 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $15.90 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.25 | 12 | Alkermes, Inc. ($108.97) |
| 2023 | $221.89 | 2 | ITI, Inc. ($124.99) |
| 2022 | $402.52 | 5 | ITI, Inc. ($245.48) |
| 2021 | $476.88 | 4 | Alkermes, Inc. ($350.12) |
| 2018 | $28.95 | 1 | Merck Sharp & Dohme Corporation ($28.95) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Central Nervous System | ||||||
| 10/31/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Neuroscience | ||||||
| 08/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Neurology | ||||||
| 07/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Neuropsychiatry | ||||||
| 04/23/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $108.97 | General |
| Category: CNS | ||||||
| 09/20/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $96.90 | General |
| Category: CNS | ||||||
| 06/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 08/16/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $130.28 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Neurology | ||||||
| 03/11/2022 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: UPLIZNA | ||||||
| 02/08/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: PSYCHIATRY | ||||||
| 01/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $123.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: CNS | ||||||
| 12/09/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 11/22/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $100.86 | General |
| Category: CNS | ||||||
| 11/10/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $126.76 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: WOMENS HEALTH | ||||||
About Dr. Sydur Rahman, M.D
Dr. Sydur Rahman, M.D is a Child & Adolescent Psychiatry healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1750771085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sydur Rahman, M.D has received a total of $1,450 in payments from pharmaceutical and medical device companies, with $320.25 received in 2024. These payments were reported across 24 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,450).
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Pittsburgh, PA
- Active Since 01/26/2015
- Last Updated 06/11/2024
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1750771085
Products in Payments
- CAPLYTA (Drug) $497.23
- LYBALVI (Drug) $334.09
- VIVITROL (Drug) $125.00
- VRAYLAR (Drug) $123.77
- ARISTADA (Drug) $96.90
- INVEGA SUSTENNA (Drug) $58.83
- UZEDY (Drug) $42.44
- Austedo XR (Drug) $35.88
- NEXPLANON (Drug) $28.95
- HETLIOZ (Drug) $22.85
- ABILIFY MAINTENA (Drug) $21.52
- TYSABRI (Biological) $17.37
- REXULTI (Drug) $16.01
- UPLIZNA (Drug) $15.90
- INGREZZA (Drug) $13.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Pittsburgh
S. Kreps, M.d, M.D
Child & Adolescent Psychiatry — Payments: $8,182
Dr. Lisa Pan, M.d, M.D
Child & Adolescent Psychiatry — Payments: $256.28
Miss. Teresa Lutka, Md, MD
Child & Adolescent Psychiatry — Payments: $161.23
Henry Patrick Driscoll
Child & Adolescent Psychiatry — Payments: $131.89
Valerie Miller, M.d, M.D
Child & Adolescent Psychiatry — Payments: $124.13
Rachel Whelan
Child & Adolescent Psychiatry — Payments: $91.31